7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,884.90

-146.50

-3.63%

77,033.10

-983.85

-1.26%

Crude Oil Dec 26

102.95

+0.95

+0.93%

US Private Equity

10,850.63

-82.20

-0.75%

Merck KgaA Is Paying More Than Double for This Gene-Silencing Biotech, Which Is Soaring 125%

Merck KgaA Is Paying More Than Double for This Gene-Silencing Biotech, Which Is Soaring 125% · Barrons.com · Courtesy of Merck KGaA

Mackenzie Tatananni

October 19, 2026 3 min read

Silence Therapeutics stock surges as Merck KGaA agrees to acquire the RNA drugmaker for over $1 billion.

Continue Reading

Terms and Privacy Policy

Your Privacy Choices

Mobilize your Website

View Site in Mobile | Classic

Share by: